Delcath Systems, Inc.
DCTH- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000872912
No open-market purchases or sales by Delcath Systems, Inc. insiders were filed in the last 90 days; 119 institutions reported holding it in 13F filings for Q2 2026, worth $219.2M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Delcath Systems, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 25 | 29 | +4 |
| Shares | 1.44M | 1.31M | −129.0K (−9.0%) |
| Value | $15.0M | $10.1M | −$4.87M (−32.4%) |
New holders (8)
Institutions that held Delcath Systems, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| CIBC World Markets Inc. | 85,319 | $661.0K | 0.00% |
| Susquehanna International Group, LLP | 27,008 | $209.0K | 0.00% |
| Two Sigma Investments, LP | 18,209 | $141.0K | 0.00% |
| Virtu Financial LLC | 14,771 | $114.0K | 0.01% |
| Two Sigma Securities, LLC | 10,740 | $83.0K | 0.02% |
| Royal Bank of Canada | 1,500 | $12.0K | 0.00% |
| National Bank of Canada | 1 | $0 | 0.00% |
| Umb Bank N A | 2 | $0 | 0.00% |
Sold out (4)
Institutions that held Delcath Systems, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Adage Capital Partners GP, L.L.C. | 250,000 | $2.61M |
| Schonfeld Strategic Advisors LLC | 81,600 | $851.0K |
| Ikarian Capital, LLC | 44,857 | $468.0K |
| Tower Research Capital LLC (TRC) | 554 | $6.00K |